Article info

Download PDFPDF

107 Empagliflozin in heart failure with a preserved ejection fraction ≥50%: results from the emperor-preserved clinical trial
Free

Authors

Citation

Yousef Z
107 Empagliflozin in heart failure with a preserved ejection fraction ≥50%: results from the emperor-preserved clinical trial

Publication history

  • First published June 6, 2022.
Online issue publication 
June 06, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.